| Development of an easily bioconjugatable water-soluble single-photon emission-computed tomography/optical imaging bimodal imaging probe based on the aza-BODIPY fluorophore M Privat, PS Bellaye, R Lescure, A Massot, O Baffroy, M Moreau, ... Journal of Medicinal Chemistry 64 (15), 11063-11073, 2021 | 17 | 2021 |
| Near-infrared emitting fluorescent homobimetallic gold (I) complexes displaying promising in vitro and in vivo therapeutic properties R Lescure, M Privat, J Pliquett, A Massot, O Baffroy, B Busser, PS Bellaye, ... European Journal of Medicinal Chemistry 220, 113483, 2021 | 12 | 2021 |
| NIR-II aza-BODIPY dyes bioconjugated to monoclonal antibody trastuzumab for selective imaging of HER2-positive ovarian cancer A Godard, G Kalot, M Privat, M Bendellaa, B Busser, KD Wegner, F Denat, ... Journal of Medicinal Chemistry 66 (7), 5185-5195, 2023 | 8 | 2023 |
| First Comparison Study of the In Vitro and In Vivo Properties of a Randomly and Site-Specifically Conjugated SPECT/NIRF Monomolecular Multimodal Imaging … M Privat, PS Bellaye, E Chazeau, C Racoeur, P Adumeau, D Vivier, ... Bioconjugate Chemistry 34 (4), 621-628, 2023 | 5 | 2023 |
| Conception and Evaluation of Fluorescent Phosphine‐Gold Complexes: From Synthesis to in vivo Investigations B Rousselle, A Massot, M Privat, L Dondaine, A Trommenschlager, ... ChemMedChem 17 (11), e202100773, 2022 | 5 | 2022 |
| GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC N Mabrouk, C Racoeur, J Shan, A Massot, S Ghione, M Privat, ... Cancers 15 (12), 3129, 2023 | 2 | 2023 |
| Front Cover: Conception and Evaluation of Fluorescent Phosphine‐Gold Complexes: From Synthesis to in vivo Investigations (ChemMedChem 11/2022) B Rousselle, A Massot, M Privat, L Dondaine, A Trommenschlager, ... ChemMedChem 17 (11), e202200295, 2022 | 1 | 2022 |
| Comparison of the In Vitro and In Vivo Behavior of a Series of NIR-II-Emitting Aza-BODIPYs Containing Different Water-Solubilizing Groups and Their Trastuzumab Antibody Conjugates E Chazeau, C Fabre, M Privat, A Godard, C Racoeur, E Bodio, B Busser, ... Journal of Medicinal Chemistry, 2024 | | 2024 |
| Development of an Immuno-SPECT/Fluorescent Bimodal Tracer Targeting Human or Murine PD-L1 on Preclinical Models M Privat, A Massot, F Hermetet, H Al Sabea, C Racoeur, N Mabrouk, ... Journal of Medicinal Chemistry, 2024 | | 2024 |
| Development of an easily bioconjugatable water-soluble SPECT/Optical bimodal imaging probe to target the cancer biomarkers PD-L1 and HER-2 C Goze, M Privat, P Bellaye, R Lescure, A Massot, D Vivier, P Adumeau, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Preclinical imaging of CD8 T-Cells as a tool to predict response to immunotherapy C Paul, D Vivier, A Massot, L DaCosta, P Baurand, M Desbuisson, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy D Vivier, A Massot, PE Baurand, L Da Costa, M Privat, M Moreau, ... Nuclear Medicine and Biology 108, S218-S219, 2022 | | 2022 |
